Author:
Tanaka Naoki,Horiuchi Akira,Yamaura Takahiro,Komatsu Michiharu,Yokoyama Takahide,Okaniwa Shinji,Nagaya Tadanobu,Yoshizawa Kaname,Kiyosawa Kendo,Aoyama Toshifumi,Tanaka Eiji
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990;12:671–5.
2. Tarao K, Rino Y, Ohkawa S, Endo O, Miyakawa K, Tamai S, et al. Sustained low alanine aminotransferase levels can predict the survival for 10 years without hepatocellular carcinoma development in patients with hepatitis C virus-associated liver cirrhosis of Child stage A. Intervirology. 2004;47:65–71.
3. Tanaka N, Kiyosawa K. Phlebotomy: a promising treatment for chronic hepatitis C. J Gastroenterol. 2004;39:601–3.
4. Kaito M. Molecular mechanism of iron metabolism and overload in chronic hepatitis C. J Gastroenterol. 2007;42:96–9.
5. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 1994;89:986–8.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献